Portfolio
Entities in which TLS members hold minority ownership positions include:

A mission-driven oncology company focused on developing and commercializing critical medicines for the treatment cancer.

Technology solution for real-time pharmacy data and analytics

PatientFinder
Healthcare analytics for life sciences companies. Purchased by Definitive Health in 2020.